Home/Filings/4/0001437749-21-022213
4//SEC Filing

Simpson Jennifer K. 4

Accession 0001437749-21-022213

CIK 0001029125other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 6:00 PM ET

Size

5.2 KB

Accession

0001437749-21-022213

Insider Transaction Report

Form 4
Period: 2021-09-13
Simpson Jennifer K.
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-09-13+19,12519,125 total
    Exercise: $2.26Exp: 2031-09-13Common Stock (19,125 underlying)
Footnotes (1)
  • [F1]The stock option is schedule to vest in three equal annual installments on September 13, 2022, 2023 and 2024.

Issuer

Panbela Therapeutics, Inc.

CIK 0001029125

Entity typeother

Related Parties

1
  • filerCIK 0001545253

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 6:00 PM ET
Size
5.2 KB